Hear From Our Clients
Bill Niland
CEO at ReGelTec
Bill Niland, CEO at ReGelTec Inc., gives a testimonial about his experience with his early feasibility first-in-human clinical study with bioaccess® in Colombia.
Bill Andrews, PhD
President & CEO at Sierra Sciences
Sierra Sciences is a biotech company based in Reno, NV, with a 10,000 sq. ft. state-of-the-art lab, with the primary mission to extend the human lifespan and health span through telomere maintenance. Sierra Sciences focuses exclusively on research and licenses compounds to companies that develop products and take them to market.
Dushyanth Surakanti
Founder & CEO of Sparta Biomedical
Dushyanth Surakanti is the Founder and CEO of Sparta Biomedical. He shares his experience with bioaccess® during its first human trial in Colombia.
John Simpson, MD
CEO at Avinger
Dr. John B. Simpson, CEO of Avinger, Inc., speaks about Avinger's satisfactory experience conducting OCT-guided atherectomy clinical research at a research site in Cali, Colombia.
Topher Kinsella, MD
CEO at Watershed Therapeutics
Christopher Kinsella, CEO at Watershed Therapeutics, shares his experience conducting a clinical trial in Barranquilla, Colombia, and his collaboration with bioaccess®.